| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_307ca182a7a569af55e7a483090b4909
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d416821be15255b0d3776035f520afbe |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-38 |
| filingDate |
2008-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff6a862313c575b067832f976ff38fcf |
| publicationDate |
2012-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8329744-B2 |
| titleOfInvention |
Methods of preventing the serotonin syndrome and compositions for use thereof |
| abstract |
The present invention is directed at methods for preventing or minimizing the intensity of the serotonin syndrome in humans and lower animals which comprises administering proserotonergic agents and serotonin surge protectors. The present invention is also directed to pharmaceutical compositions comprising proserotonergic agents and serotonin surge protectors useful for carrying out the method of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11077055-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8952117-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10632201-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10835488-B2 |
| priorityDate |
2005-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |